Jonathan Baliff
CIK 1434006 · View on SEC EDGAR ↗
First SEC filing: May 5, 2008 · Latest: May 5, 2008
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 2, 2021 | RDW | P | 5,000 | $10.00 | $50,000 | 5,000 Direct | — | Acquired | 20.2% (price as of 2026-08-19) |
| May 27, 2021 | TCBIO | S | 976 | $69.16 | $67,500 | 5,257 Direct | -15.66% | Disposed | -70.3% (price as of 2026-08-19) |
| July 26, 2017 | TCBIO | P | 25 | $81.55 | $2,039 | 1,195 Direct | +2.14% | Acquired | -74.8% (price as of 2026-08-19) |
| Sept. 9, 2008 | NRG | P | 1,000 | $30.99 | $30,990 | 9,500 Direct | +11.76% | Acquired | 276.3% (price as of 2026-08-19) |
| Sept. 9, 2008 | NRG | P | 1,000 | $31.77 | $31,770 | 8,500 Direct | +13.33% | Acquired | 267.0% (price as of 2026-08-19) |
| Sept. 9, 2008 | NRG | P | 3,500 | $32.20 | $112,700 | 7,500 Direct | +87.50% | Acquired | 262.1% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 23, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Disposed |
| April 22, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (1,670) | $0.00 | — | 1,670 | Acquired |
| April 23, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Acquired |
| April 18, 2024 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Disposed |
| April 19, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,377) | $0.00 | — | 1,377 | Disposed |
| April 18, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Acquired |
| Jan. 4, 2010 | NRG | Performance Units | Common Stock, par value $.01 per share (17,400) | — | Jan. 4, 2013 | 8,700 | Acquired |
| Jan. 4, 2010 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share (18,800) | $23.87 | Jan. 4, 2020 | 18,800 | Acquired |
| Jan. 2, 2009 | NRG | Performance Units | Common Stock, par value $.01 per share (16,000) | — | Jan. 2, 2012 | 16,000 | Acquired |
| Jan. 2, 2009 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share (33,300) | $23.64 | Jan. 2, 2015 | 33,300 | Acquired |
| May 1, 2008 | NRG | Performance Units | Common Stock, par value $.01 per share (15,400) | — | May 1, 2011 | 15,400 | Acquired |
| May 1, 2008 | NRG | Non-Qualified Stock Options | Common Stock, par value $.01 per share (40,000) | $42.67 | May 1, 2014 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 5, 2008 | NRG | No securities beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RDW
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $444,615 | — | $1,883,067 | — | $110,042 | — | $855,832 | $3,293,556 |
| 2024 | $417,308 | — | $2,403,768 | — | $209,697 | — | $24,060 | $3,054,833 |
| 2023 | $400,000 | — | $520,200 | — | $386,587 | — | $36,755 | $1,343,542 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.